Patient demographics and a comparison of self-reported tobacco use against urinary cotinine levels as determined by the SmokeScreen® test
| Patient demographics (n = 100) | |||||||||||
| Sex | Male 56% | Female 44% | |||||||||
| Age | Mean + SD 35.6+12.1 | Median (range) 33 (17–74) | |||||||||
| Place of origin | U. K. 11% | Africa 27% | Indian subcontinent 52% | South East Asia 4% | Caribbean 4% | ||||||
| Year of entry to U. K. | Before 2000 18% | After 2000 72% | |||||||||
| Weight | Mean + SD 65.8+10.6kg | Median (range) 65 (38–94) | |||||||||
| Creatinine | Mean + SD 65.3+15 mol/L | Median (range) 63 (35–103) | |||||||||
| Estimated Glomerular Filtration rate | >60mls/min 100% | <60mls/min 0% | |||||||||
| Liver function | Normal 96% | Abnormal 4% | |||||||||
| Alcohol consumption | No Alcohol 89% | Regular alcohol 11% | |||||||||
| Recreation drug use | Yes 2% | No 98% | |||||||||
| HIV status | Positive 1% | Negative 99% | |||||||||
| Smoking history and SmokeScreenTM results | |||||||||||
| Smoking History (n = 100) | SmokeScreen® (n = 100) | ||||||||||
| Negative | Light | Moderate | Heavy | Very heavy | |||||||
| No tobacco | 81 | 71 | 2 | 2 | 5 | 1 | |||||
| Total Smokers | 17 | 4 | 2 | 0 | 3 | 8 | |||||
| 1–5 Cigarettes / day | 9 | 2 | 2 | 0 | 2 | 3 | |||||
| 6–10 Cigarettes / day | 6 | 2 | 0 | 0 | 1 | 3 | |||||
| 11–15 Cigarettes / day | 2 | 0 | 0 | 0 | 0 | 2 | |||||
| Chew tobacco | 2 | 0 | 0 | 0 | 1 | 1 | |||||